Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Rocco Haase"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundSiponimod, a second-generation, selective sphingosine 1-phosphate receptor (S1PR) 1 and 5 modulator, represents an important therapeutic choice for active secondary progressive multiple sclerosis (SPMS). Besides the beneficial immunomodulat
Externí odkaz:
https://doaj.org/article/4788640b20564c2682851b0bdf77c572
Autor:
Magdalena Mueller-Enz, Christina Woopen, Georges Katoul Al Rahbani, Rocco Haase, Marie Dunsche, Tjalf Ziemssen, Katja Akgün
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
ImportanceImmunological response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination is important, especially in people with multiple sclerosis (pwMS) on immunosuppressive therapies.ObjectiveThis study aims to determine whethe
Externí odkaz:
https://doaj.org/article/82619fd6273546f6a9185b56d0d6cdb5
Autor:
Undine Proschmann, Puya Shalchi-Amirkhiz, Pauline Andres, Rocco Haase, Hernán Inojosa, Tjalf Ziemssen, Katja Akgün
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
ObjectiveThe study aimed to investigate the effect of exercise on immune cell count and cell mechanical properties in people with multiple sclerosis (pwMS) on different disease-modifying treatments (DMT) vs. healthy controls (HCs).MethodsA cohort of
Externí odkaz:
https://doaj.org/article/b546a686935b46408e453e9ea1b3572d
Autor:
Christina Woopen, Marie Dunsche, Georges Katoul Al Rahbani, Anja Dillenseger, Yassin Atta, Rocco Haase, Catarina Raposo, Rosetta Pedotti, Tjalf Ziemssen, Katja Akgün
Publikováno v:
Vaccines, Vol 11, Iss 9, p 1464 (2023)
Our objective was to analyze longitudinal cellular and humoral immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in people with multiple sclerosis (pwMS) on B-cell depleting treatment (BCDT) compared to pwMS
Externí odkaz:
https://doaj.org/article/0e428f05387f4120a91157b0250cecc1
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 15 (2022)
Sphingosine 1-phosphate (S1P) receptor (S1PR) modulators have a complex mechanism of action, which are among the most efficient therapeutic options in multiple sclerosis (MS) and represent a promising approach for other immune-mediated diseases. The
Externí odkaz:
https://doaj.org/article/661199a33596425db514affe81423f17
Autor:
Undine Proschmann, Puya Shalchi Amirkhiz, Pauline Andres, Rocco Haase, Hernan Inojosa, Tjalf Ziemssen, Katja Akgün
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 17, p 13479 (2023)
Lymphocytes are key players in the pathogenesis of multiple sclerosis and a distinct target of several immunomodulatory treatment strategies. In this study, we aim to evaluate the effect of various pre-analytic conditions on immune cell counts to con
Externí odkaz:
https://doaj.org/article/d5bbea7d3c9f4bfab595c51596f7de51
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
ObjectiveTo determine the transfer of the monoclonal antibody natalizumab into breastmilk and to evaluate drug and serum neurofilament light chain ((s)NfL) levels in natalizumab exposed pregnancies and lactation periods.MethodsEleven women with relap
Externí odkaz:
https://doaj.org/article/9e76da2637a444dba32f1468ba7ea349
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
An individualized innovative disease management is of great importance for people with multiple sclerosis (pwMS) to cope with the complexity of this chronic, multidimensional disease. However, an individual state of the art strategy, with precise adj
Externí odkaz:
https://doaj.org/article/6f73b84080cc44d7b83373eaee8b783a
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 13 (2020)
Background: For the case of multiple sclerosis, research on gender differences from a health economics perspective has not received much attention. However, cost-of-illness analyses can provide valuable information about the diverse impact of the dis
Externí odkaz:
https://doaj.org/article/6c46fbda0f4e4dae9c30f5a02d02394c
Autor:
Katrin Trentzsch, Marie Luise Weidemann, Charlotte Torp, Hernan Inojosa, Maria Scholz, Rocco Haase, Dirk Schriefer, Katja Akgün, Tjalf Ziemssen
Publikováno v:
Frontiers in Neuroscience, Vol 14 (2020)
Walking impairments represent one of the most debilitating symptom areas for people with multiple sclerosis (MS). It is important to detect even slightest walking impairments in order to start and optimize necessary interventions in time to counterac
Externí odkaz:
https://doaj.org/article/e2e5bd55e8894969b47aaec7dd1b1f07